Anticonvulsive and neuroprotective effects of synergetic combination of phenytoin and gastrodin on the convulsion induced by penicillin in mice. (15th June 2015)
- Record Type:
- Journal Article
- Title:
- Anticonvulsive and neuroprotective effects of synergetic combination of phenytoin and gastrodin on the convulsion induced by penicillin in mice. (15th June 2015)
- Main Title:
- Anticonvulsive and neuroprotective effects of synergetic combination of phenytoin and gastrodin on the convulsion induced by penicillin in mice
- Authors:
- Zhou, Ziqi
Lin, Yanzhu
Zheng, Hongyi
He, Yuzhong
Xu, Haohua
Zhang, Siheng
Weng, Wen
Li, Wei
Zhu, Linyan
Yang, Haifeng - Abstract:
- <abstract abstract-type="main" id="fcp12127-abs-0001"> <title>Abstract</title> <p>Phenytoin (PHT) is a commonly prescribed first‐line antiepileptic drug. However, long‐term administration of PHT can cause memory loss and balance disturbance. Gastrodin (GD) is the major bioactive component in Tianma and has sedative, anticonvulsive, memory strengthening, and neuroprotective effects. To combine the two drugs seems attractive; however, little was known about the efficacy of combination therapy. In this study, convulsive attack was successfully induced by penicillin. Isobolographic analysis, memory and balance behavior test, histopathological examination, and Western blot analysis were used to investigate whether the combination therapy of GD and PHT can enhance anticonvulsive effect and reduce the side effects associated with PHT. The GD alone (950.60 mg/kg) and the PHT alone (45.50 mg/kg) could produce an anticonvulsive effect, while comparable effect could be produced by PHT : GD = 1 : 50 (8.59 : 429.27 mg/kg), which reduce the dose of PHT by 81% and GD by 55%. After the chronic anticonvulsive experiments of 16 days, the balance disturbance and short‐/long‐term memory loss were observed in the PHT group, while the PHT + GD therapy can protect the normal balance and memory function. The neuron morphology of hippocampus was preserved, and the number of surviving neurons after combination therapy was more than the model group. The amount of NF‐κB (p65) expression was increased<abstract abstract-type="main" id="fcp12127-abs-0001"> <title>Abstract</title> <p>Phenytoin (PHT) is a commonly prescribed first‐line antiepileptic drug. However, long‐term administration of PHT can cause memory loss and balance disturbance. Gastrodin (GD) is the major bioactive component in Tianma and has sedative, anticonvulsive, memory strengthening, and neuroprotective effects. To combine the two drugs seems attractive; however, little was known about the efficacy of combination therapy. In this study, convulsive attack was successfully induced by penicillin. Isobolographic analysis, memory and balance behavior test, histopathological examination, and Western blot analysis were used to investigate whether the combination therapy of GD and PHT can enhance anticonvulsive effect and reduce the side effects associated with PHT. The GD alone (950.60 mg/kg) and the PHT alone (45.50 mg/kg) could produce an anticonvulsive effect, while comparable effect could be produced by PHT : GD = 1 : 50 (8.59 : 429.27 mg/kg), which reduce the dose of PHT by 81% and GD by 55%. After the chronic anticonvulsive experiments of 16 days, the balance disturbance and short‐/long‐term memory loss were observed in the PHT group, while the PHT + GD therapy can protect the normal balance and memory function. The neuron morphology of hippocampus was preserved, and the number of surviving neurons after combination therapy was more than the model group. The amount of NF‐κB (p65) expression was increased in combination group. All above suggested the potential of the combination of PHT and GD enhances the anticonvulsive effect and the neuroprotective effect and reduces the PHT‐associated memory and balance disturbance. The PHT + GD strategy would provide new possibilities as a novel promising methodology to treat epileptic patients.</p> </abstract> … (more)
- Is Part Of:
- Fundamental & clinical pharmacology. Volume 29:Number 4(2015)
- Journal:
- Fundamental & clinical pharmacology
- Issue:
- Volume 29:Number 4(2015)
- Issue Display:
- Volume 29, Issue 4 (2015)
- Year:
- 2015
- Volume:
- 29
- Issue:
- 4
- Issue Sort Value:
- 2015-0029-0004-0000
- Page Start:
- 371
- Page End:
- 381
- Publication Date:
- 2015-06-15
- Subjects:
- Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=fcp ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1472-8206 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/fcp.12127 ↗
- Languages:
- English
- ISSNs:
- 0767-3981
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4056.033000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3745.xml